로딩 중…
지수 로딩 중…
Replimune Group, Inc.
REPL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$10.15+1.50%
2026-06-18
Price Chart
Replimune Group, Inc.+6.95%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $838M |
| Revenue | $0.00 |
| Net Income | $-315M |
| Total Assets | $334M |
| Net Assets | $211M |
| Value | |
| P/B | 3.98x |
| FCF Yield | -33.80% |
| Profitability | |
| ROE | -149.55% |
| ROA | -94.38% |
| Financial Health | |
| Debt Ratio | 58.45% |
| Total Debt | $76M |
| FCF | $-283M |
| Cash | $123M |
| Current Ratio | 5.60x |
| Performance | |
| 1Y Return | 6.95% |
| 1M Return | 115.96% |
| From 52W High | -23.34% |
| 1Y MDD | -86.54% |
| Trading | |
| Volume | 2,466,524 shares |
| Trading Value | $25M |
| Per Share | |
| EPS | $-3.42 |
| BPS | $2.28 |